MedPath

study on prolongation of spinal analgesia using Inj Bupivacaine 0.5% (H) and Inj Bupivacaine 0.5% (H) with Inj Clonidine 60 µ as a single shot Intrathecal injection.

Phase 4
Conditions
Health Condition 1: null- Patients undergoing lower abdomen and lower limb surgeries
Registration Number
CTRI/2012/04/002556
Lead Sponsor
Peoples Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

ASA Grade I & II patients undergoing lower abdomen and lower limb surgeries.

Exclusion Criteria

All the patients who have contraindications to spinal anesthesia will be excluded. Patients undergoing emergency surgeries and pregnant patients will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
motor block regession in bromage score,sensory block regession by pin prick senstion to dermatomes,time to requirement to first analgesic in post operative period,any other side effects like nausea,headache,itching etcTimepoint: 4 to 8 hours after intra thecal injection
Secondary Outcome Measures
NameTimeMethod
sensory block regession by pin prick senstion to dermatomes,time to requirement to first analgesic in post operative period, any other side effects like nausea,headache,itching etcTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath